TBL-0404

N/A

Report date: 2025/01/26 16:02:13
NME

Base Information

Drug NameTBL-0404
Drug Alias NamemiRNA therapy (Transgene Biotek)TBL-0404
ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Oligonucleotide > microRNA
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsCarcinoma, Hepatocellular
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryIndia
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesTransgene Biotek Ltd
China Registration ClassN/A

Develop Information

Active CompaniesTransgene Biotek Ltd
Inactive CompaniesN/A
Active IndicationsCarcinoma, Hepatocellular
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A